在类风湿性关节炎中使用生物疗法的初始治疗
Jesús Tornero Molina1,2, Blanca Hernández-Cruz3, Héctor Corominas4,5
1Departamento de Reumatología, Hospital de Guadalajara, 19002 Guadalajara, Spain.
Journal of clinical medicine
|January 11, 2024
概括
用生物疗法治疗风湿性关节炎 (RA) 的初始治疗,如TNF-α抑制剂,是有效和安全的. 这种方法,特别是在预后因素不佳的患者中,与甲状腺素单一治疗相比,显示出更好的结果.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性关节炎 (RA) 在治疗有效性和效率方面带来了重大挑战.
- 生物疗法已经成为RA管理的关键研究领域.
研究的目的:
- 分析类风湿性关节炎 (RA) 初始生物疗法的有效性,效率和安全性.
- 在早期的RA治疗中,比较生物疗法与甲状腺素单一疗法.
主要方法:
- 进行了对 RA 初始生物疗法随机临床试验的范围审查.
- 分析了十七项研究的数据,使用Jadad尺度评估质量.
- 风湿性关节炎专家讨论了研究结果,以产生治疗原则.
主要成果:
- 用TNF-α抑制剂和IL6R抑制剂 (单独或与甲醇合) 进行初始治疗对RA活性,功能和生活质量是有效的.
- 生物疗法在短期和中期表现出优于甲状腺素单一治疗的优势.
- 长期的结果有利于最初用生物药物治疗的患者,而不是甲状腺素.
结论:
- 用生物疗法治疗RA的初始治疗是有效的,高效的,安全的短期,中期和长期.
- 生物疗法对风湿性关节炎患者具有不良预后因素特别有益.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
Autoimmune Disorders
442
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
442
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K


